Ensysce Biosciences, Inc.
ENSC
$1.59
$0.031.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -663.48% | 11.90% | 37.58% | -1.74% | 124.61% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -- |
| Total Other Non-Cash Items | 433.51% | 1,138.42% | 6.95% | -92.45% | -58.71% |
| Change in Net Operating Assets | 203.74% | -215.37% | 112.07% | 270.96% | -545.07% |
| Cash from Operations | -82.91% | -17.19% | 49.91% | 57.59% | 54.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 43.98% | 52.93% | 92.61% | 33.36% | 30.34% |
| Issuance of Common Stock | -10.37% | -- | -30.22% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.21% | -- | -103.36% | -- | -- |
| Cash from Financing | -64.86% | 3,744.53% | -77.89% | -92.29% | 4,129.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.31% | 64.39% | -119.71% | -91.17% | 231.51% |